ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 104 filers reported holding ENDOLOGIX INC in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $66,000 | -8.3% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $72,000 | -33.3% | 15,000 | 0.0% | 0.00% | -33.3% |
| Q1 2017 | $108,000 | +27.1% | 15,000 | 0.0% | 0.01% | +20.0% |
| Q4 2016 | $85,000 | -38.4% | 15,000 | +38.9% | 0.01% | -37.5% |
| Q3 2016 | $138,000 | +3.0% | 10,800 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $134,000 | – | 10,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Capital Management, LLC | 4,050,000 | $49,653,000 | 5.91% |
| Essex Woodlands Management, Inc. | 1,257,468 | $21,220,000 | 3.88% |
| PURA VIDA INVESTMENTS, LLC | 205,100 | $2,515,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,347,113 | $28,776,000 | 1.11% |
| First Light Asset Management, LLC | 180,963 | $2,219,000 | 1.10% |
| ArrowMark Colorado Holdings LLC | 2,889,546 | $35,426,000 | 0.97% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,149,949 | $26,358,000 | 0.78% |
| Iguana Healthcare Management, LLC | 150,000 | $1,839,000 | 0.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,492,443 | $18,297,000 | 0.66% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 85,882 | $1,053,000 | 0.66% |